Tesofensine.
An investigational triple monoamine reuptake inhibitor for weight loss and appetite control.
Pricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
- Adults pursuing physician-supervised weight loss who have not responded to other therapies
- Patients seeking strong appetite control with adjunctive metabolic support
- Patients combining it with cognitive support under provider direction
This isn't for you if
Possible side effects include elevated heart rate, blood pressure, insomnia, and dry mouth. Not appropriate with cardiovascular disease, psychiatric instability, or stimulant medications. Specialist supervision required.
Tesofensine
Tesofensine is an oral compound studied for its powerful appetite-suppressing and metabolism-boosting effects. It works by modulating three brain chemicals — dopamine, serotonin, and norepinephrine.
Mechanism and fit.
By increasing dopamine, serotonin, and norepinephrine signaling, Tesofensine helps reduce hunger and cravings while modestly raising metabolic rate.
Who this is typically for.
- Adults pursuing physician-supervised weight loss who have not responded to other therapies
- Patients seeking strong appetite control with adjunctive metabolic support
- Patients combining it with cognitive support under provider direction
What patients
most often ask.
Why does Tesofensine require closer monitoring?
Because it increases dopamine, serotonin, and norepinephrine signaling, it can elevate heart rate, blood pressure, and impact sleep or mood. Close provider supervision is required.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <ul><li>Adults pursuing physician-supervised weight loss who have not responded to other therapies</li><li>Patients seeking strong appetite control with adjunctive metabolic support</li><li>Patients combining it with cognitive support under provider direction</li></ul>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- DosingOnce daily oral, provider-directed.
- Typical durationProvider-directed cycles with close monitoring.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering Tesofensine, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.